搜索临床试验以:CDKL5 mutation
总计3295个结果
-
Seoul St. Mary's HospitalNovartis未知
-
Seoul St. Mary's HospitalBristol-Myers Squibb未知
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)未知
-
University Hospital Birmingham未知
-
Memorial Sloan Kettering Cancer CenterBoehringer Ingelheim; National Comprehensive Cancer Network撤销
-
Sidney Kimmel Cancer Center at Thomas Jefferson...National Cancer Institute (NCI)未知
-
University of Sheffield未知
-
National University Hospital, Singapore未知
-
National University Hospital, Singapore完全的
-
Assistance Publique - Hôpitaux de ParisInstitut Pasteur完全的
-
Sheba Medical Center完全的
-
National Taiwan University Hospital未知
-
Jin Il KimKorean College of Helicobacter and Upper Gastrointestinal Research完全的
-
Children's Cancer and Leukaemia Group未知
-
Lawrence Livermore National Laboratory at University...National Cancer Institute (NCI)未知
-
The Christie NHS Foundation Trust未知肉瘤 | 宫颈癌 | 乳腺癌 | 卵巢癌 | 输卵管癌 | 前列腺癌 | 外阴癌 | 子宫内膜癌 | 阴道癌 | 原发性腹膜腔癌英国
-
The University of New South Wales完全的
-
University College London Hospitals完全的乳腺癌 | 遗传性乳腺癌/卵巢癌(brca1、brca2) | brca1突变携带者 | brca2突变携带者澳大利亚, 以色列, 英国, 西班牙, 瑞典, 葡萄牙
-
University of Alabama at BirminghamNational Cancer Institute (NCI)撤销卵巢癌 | brca1突变携带者 | brca2突变携带者美国
-
Leeds Cancer Centre at St. James's University Hospital未知
-
Leeds Cancer Centre at St. James's University Hospital未知
-
Cancer Research Centre at Weston Park Hospital未知
-
Leeds Cancer Centre at St. James's University Hospital未知
-
Cambridge University Hospitals NHS Foundation Trust未知
-
National Cancer Institute (NCI)未知
-
Cytonet GmbH & Co. KGCRS Clinical Research Services Mannheim GmbH完全的
-
Pfizer完全的要旨美国, 瑞士, 比利时, 丹麦, 西班牙, 英国, 澳大利亚, 印度, 法国, 斯洛伐克, 加拿大, 芬兰, 德国, 大韩民国, 荷兰, 波兰
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)完全的